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INTRODUCTION
INTRODUCTION
Oral route of drug administration is the most appealing route for the delivery of
drugs. Oral route of drug forms administration have wide acceptance up to 50-60 % of
total dosage forms1.Solid dosage forms are popular because of ease of administration,
accurate  dosage,  self-medication,  pain  avoidance  leading  to  high  level  of  patient
compliance. The most popular solid dosage forms are being tablets and capsules.
Tablet is the most common and popular oral dosage form prepared and available
in the market and preferred by the patients and physicians alike. Tablet is the most widely
used dosage form because of its convenience in terms of self-administration, compactness
and ease in manufacturing2. For any drug to exhibit its prompt pharmacological action, its
serum concentration has to reach optimum level within a short period of time. Tablets
constitute major portion of drug delivery systems that are currently available. However,
many patient groups, such as the elderly, children and patients who are mentally retarded,
non-cooperative, nauseated or on reduced liquid intake/diets have difficulties swallowing
these dosage forms. Those who are travelling or have little access to water are similarly
affected.  To overcome these problems pharmaceutical  technologists  have developed a
novel oral dosage form known as Oro Dispersible Tablet (ODT). 
Oro dispersible tablets are those tablets which disperses upon contact  with the
mucosal  surfaces  of  the  oral  cavity  and  quickly  release  their  components  without
mastication or water before swallowing.  Oro dispersible tablets disintegrate rapidly in
saliva,  usually  in  matter  of  seconds,  without  the  need  of  taking  water.  Thus  drug
dissolution and absorption as well as onset of clinical effect can be obtained significantly
quicker than that of conventional dosage forms. Faster the drug in solution quicker the
absorption and rapid onset of action3,4.
These tablets are also called as orodispersible tablets, quick disintegrating tablets,
mouth  dissolving  tablets,  fast  disintegrating  tablets,  fast  dissolving  tablets,  rapid
dissolving tablets, porous tablets and rapimelts. However, of all the above terms, United
States  of  Pharmacopoeia  (USP)  approved  these  dosage  forms  as  ODTs  (orally
Pharmacopoeia  disintegrating  tablets).  European  pharmacopeia  has  used  the  term
orodispersible  tablet  for  tablets  that  disperses  readily  within  3  min  in  mouth  before
swallowing. United States of Food and Drug Administration (FDA) defined ODT as 
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“A solid dosage form substance containing oractiveingredient which disintegrates
rapidly  usually  within  a  matter  of  seconds  when  placed  upon  the  tongue.”  The
disintegration  of  ODTs  generally  ranges  from  several  time  seconds  for  to  about  a
minute5,6.
Fig.No.1.Advantages of Orodispersible tablet 
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Rapidly dissolving tablet
↓
Placed in tongue
↓
Instantaneous disintegration in the mouth
↓
Rapid drug dispersion/dissolution in saliva
↓
Pre-gastric absorption
↓
Avoid first pass metabolism
↓
Increase in bioavailability
↓
Faster onset of action
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Drug selection criteria
The ideal characteristics of a drug for Oro Dispersible Tablet include 
 Ability to permeate the oral mucosa.
 At least partially non-ionized at the oral cavity pH.
 Have the ability to diffuse and partition into the epithelium of the upper GIT.
 Small to moderate molecular weight.
 Low dose drugs preferably less than 50 mg.
 Short half life and frequent dosing drugs are unsuitable for ODT.
 Drug should have good stability in saliva and water.
 Very  bitter  or  unacceptable  taste  and odor drugs are unsuitable for ODT7,8
 
Advantages of Orodispersible Tablets
Administration to the patients who cannot swallow, such as the elderly,  stroke
victims,  bedridden patients, patients affected by renal failure & patients who refuse to
swallow such as pediatric, geriatric & psychiatric patients . 
 Rapid drug therapy intervention. 
 Achieve increased bioavailability/rapid absorption through pre gastric absorption
of drugs from mouth, pharynx & oesophagus as saliva passes down. 
 Convenient  for  administration  and  patient  compliant  for  disabled,  bedridden
patients and for travelers and busy people, who do not always have access water. 
 Good mouth feel property helps to change the perception of medication as bitter
pill particularly in pediatric patients. 
 The risk of chocking or suffocation during oral  administration of conventional
formulations  due  to  physical  obstruction  is  avoided,  thus  providing  improved
safety. 
 New business opportunity like product differentiation, product promotion, patent
extension and life cycle management. 
 Cost effective Dosage Form
 Ideally an ODT should allow high drug loading, be compatible with taste masking
and have a pleasing mouth feel and should have sufficient strength10.
Limitations of  Orodispersible tablets
 The  tablets  usually  have  insufficient  mechanical  strength.  Hence,  careful
handling is required.
 Drugs which are relatively larger doses are difficult to formulate into ODTs.
e.g. antibiotics like ciprofloxacin with adult dose tablet containing about 500 mg
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of the drug10
Need to formulate Orodispersible tablets
The need for non‐invasive drug delivery systems continues due to patient’s poor
acceptance and compliance with existing delivery regimes, limited market size for drug
companies and drug uses coupled with high cost of disease management. ODT is one
such dosage form which is useful for Geriatric patients mainly suffering from conditions
like hand tremors and dysphasia.
 Pediatric   patients   who   are   unable   to swallow  easily  because  their  central
nervous system and internal muscles are not developed completely.
 Traveling  patients  suffering  from  motion sickness  and  diarrhea  that  do  not
have easy access to water.
 Especially   for   Patients   with   persistent nausea for a long period of time are
unable to swallow.
 Mentally   challenged   patients,   bedridden patients and psychiatric patients.
CHALLANGES IN FORMULATING ORODISPERSIBLE TABLETS
 Palatability
As most drugs are unpalatable, orally disintegrating drug delivery systems usually
contain the medicament in a taste-masked form. Delivery systems disintegrate or dissolve
in patient’s oral cavity which come in contact with the taste buds; hence, taste-masking of
the drugs becomes critical to patient compliance.
 Mechanical strength
In order to allow ODTs to disintegrate in the oral cavity, they are made of either
very  porous  and  soft-molded  matrices  or  compressed  into  tablets  with  very  low
compression force, which makes the tablets friable and/or brittle, difficult to handle and
often requiring specialized peel-off blister packing that may add to the cost. Only few
technologies can produce tablets that are sufficiently hard and durable to allow them to be
packaged  in  multidose  bottles,  such  as  Wowtab®  by  Yamanouchi-Shaklee  and
DuraSolv® by CIMA labs
 Hygroscopicity
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Several orally disintegrating dosage forms are hygroscopic and cannot maintain
physical integrity under normal conditions of temperature and humidity. Hence, they need
protection from humidity which calls for specialized product packaging.
 Amount of drug
The application of technologies used for ODTs is limited by the amount of drug
that can be incorporated into each unit dose. For lyophilized dosage forms, the drug dose
must be lower than 400 mg for insoluble drugs and less than 60 mg for soluble drugs.
This parameter is particularly important when formulating a fast-dissolving oral tablets..
 Aqueous solubility
Soluble drugs pose  various  formulation challenges  because they form eutectic
mixtures, which result in freezing-point depression and the formation of a glassy solid
that  may  collapse  upon  drying  because  of  loss  of  supporting  structure  during  the
sublimation process. Such collapse sometimes can be prevented by using various matrix-
forming  excipients  such  as  mannitol  than  can  induce  crystallinity  and  hence,  impart
rigidity to the amorphous composite.
 Size of tablet
The degree of ease when taking a tablet depends on its size. It has been reported
that the easiest size of tablet to swallow is 7-8 mm while the easiest size to handle was
one larger than 8 mm. Therefore, the tablet size is both easy to take and easy to handle is
difficult to achieve
 Mouth Feel
Orodispersible tablets should not disintegrate into larger particle in the oral cavity.
The particles generated after disintegration of orally disintegrating tablet should be small
as  possible.These  tablets   should  leave  minimal  or  no  residue  in  mouth  after   oral
administration.Addition of flavours and cooling agents improve the mouth feel15,16,17.
METHODS FOR PREPARING ORODISPERSIBLE TABLETS
(a) Tablet Molding
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Tablet produced by moulding are solid dispersion. Moulded tablets disintegrate
more rapidly and offer improved taste because the dispersion matrix is in general made
from water soluble sugars. The active ingredients in most cases are absorbed through the
mucosal lining of the mouth. Moulding process is of two types i.e. solvent method and
heat  method.  Solvent  method  involves  moistening  the  powder  blend  with  a  hydro
alcoholic solvent followed by compression at low pressures in moulded plates to form a
wetted mass (compressing moulding). The solvent is then removed by air drying. Such
tablets  are  less  compact  than  compressed  tablets  and  posses  a  porous  structure  that
hastens dissolution.
The  heat-moulding  process  involves  setting  the  molten  mass  that  contains  a
dispersed drug. The heat molding process uses an agar solution as a binder and a blister
packaging well  as a mould to manufacture a  tablet.  The process involves preparing a
suspension that contains a drug, agar and sugar (e.g., mannitol or lactose) pouring the
suspension  into  the  blister  packaging;  well  solidifying  the  agar  solution  at  room
temperature to form a jelly and drying at 30ºC under vacuum. Moulded tablets typically
do not posses great  mechanical  strength.  Erosion and breakage of  the moulded tablet
often occur during handling and opening of blister packs.
(b) Spray drying
Spray  drying  is  used  in  pharmaceutical  industries  to  produce  highly  porous
powders. The processing solvent is evaporated rapidly by spray drying, which renders the
product highly porous and fine powders can be produced. In this technique, gelatin can be
used as a supporting agent and as a matrix, mannitol as a bulking agent and Sodium
Starch  Glycolate,  Crosscarmellose,  Crospovidone  are  used  as  a  superdisintegrants.
Disintegration and dissolution was further enhanced by adding an acid (e.g. citric acid) or
an alkali (e.g. sodium bicarbonate). The formulation was spray dried to yield a porous
powder. Tablets manufactured from this powder have been reported to disintegrate in less
than 20 seconds in an aqueous medium17.
(c) Mass-Extrusion
This technology involves softening the active blend using the solvent mixture of
water soluble polyethylene glycol using methanol and expulsion of softened mass through
the extruder or syringe to get a cylinder of the product into even segments using heated
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blade to form tablets. The dried cylinder can also be used to coat granules of bitter tasting
drugs and thereby masking their bitter taste.
(d) Freeze-Drying or Lyophillization
Freeze drying is the process in which water is sublimed from the product after it is
frozen. This technique creates an amorphous porous structure that can dissolve rapidly. A
typical  procedure  involved  in  the  manufacturing  of  ODT  using  this  technique  is
mentioned here. The active drug is dissolved or dispersed in an aqueous solution of a
carrier/polymer. The mixture is done by weight and poured in the walls of the preformed
blister  packs.  The  trays  holding  the  blister  packs  are  passed  through  liquid  nitrogen
freezing tunnel to freeze the drug solution or dispersion. Then the frozen blister packs are
placed  in  refrigerated  cabinets  to  continue  the  freeze-drying.  After  freeze-drying  the
aluminum foil  backing is  applied on a blister-sealing machine.  Finally the blisters are
packaged  and  shipped.  The  freeze-drying  technique  has  demonstrated  improved
absorption  and  increase  in  bioavailability.  The major  disadvantages  of  lyophillization
technique  are  that  it  is  expensive  and  time  consuming;  fragility  makes  conventional
packaging unsuitable for these products and poor stability under stressed conditions.
(e) Sublimation
The  slow  dissolution  of  the  compressed  tablet  containing  even  highly  water-
soluble ingredients is due to the low porosity of the tablets. Inert solid ingredients that
volatilize  readily  (e.g.  urea,  ammonium  carbonate,  ammonium  bicarbonate,
hexamethelene tetramine, camphor, etc.) are added to the other tablet ingredients and the
mixture  is  compressed  into  tablets.  The  volatile  materials  are  then  removed  via
sublimation, which generates porous structures. Tablets manufactured by this technique
have  reported  to  usually  disintegrate  in  10-20  sec.  Even  solvents  like  cyclohexane,
benzene can be used as pore forming agents.
(f) Direct Compression
‟From the pharmaceutical  manufacturer s the simplest most cost-effective tablet
manufacturing procedure. Pharmaceutical companies can use conventional manufacturing
equipment  and  commonly  available  ingredients.  This  method  can  be  applied  to
manufacturing  FDTs  by  choosing  appropriate  combinations  of  excipients,  which  can
provide  fast  disintegration  and  good physical  resistance.  Sugar-based  excipients  have
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been widely used as bulking agents because of their high aqueous solubility,  pleasing
mouth-feel and good taste masking. Nearly all formulations for FDTs incorporate some
sugar materials in their formulations.
(g) Superdisintegrants addition
A disintegrant is a substance in a tablet formulation that enables the tablet to break
up into smaller fragments upon contact with gastrointestinal fluids. Superdisintegrants are
used at a low level in the solid dosage form, typically 1–10% by weight relative to the
total  weight  of  the  dosage  unit.  Examples  of  superdisintegrants  are  Crosscarmelose,
crospovidone and  sodium starch  glycolate,  which  are  a  cross  linked  cellulose,  cross-
linked polymer and a cross linked starch respectively. The proper choice of disintegrant
and  its  consistency  of  performance  are  critical  to  formulation  development  of  such
tablets.
Microcrystalline cellulose and low substituted Hydroxypropylcellulose were used
as disintegrating agents in the range of 8:2 –9:1 to prepare fast dissolving tablet. Agar
powder is used as disintegrant for the development of rapidly disintegration tablets by
enhancing the porosity of agar by water treatment. Sodium starch gycolate, crospovidone
and crosscarmellose are some of the popular superdisintegrants. The list of commonly
used superdisintegrants with their description is shown in Table 1.1
Mechanism of Superdisintegrants:
There are four major mechanisms for tablet disintegration as follows:
1.  Swelling
Perhaps  the  most  widely  accepted  general  mechanism  of  action  for  tablet
disintegration is swelling. Tablets with high porosity show poor disintegration due to lack
of adequate swelling force. On the other hand, sufficient swelling force is exerted in the
tablet with low porosity. It is worthwhile to note that if the packing fraction is very high,
fluid is unable to penetrate in the tablet and disintegration is again slows down.
2.  Porosity and capillary action (Wicking)
Disintegration by capillary action is always the first step. When we put the tablet
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into suitable aqueous medium, the medium penetrates into the tablet and replaces the air
adsorbed on the particles, which weakens the intermolecular bond and breaks the tablet
into  fine  particles.  Water  uptake  by  tablet  depends  upon  hydrophilicity  of  the  drug
/excipients and on tableting conditions. For these types of disintegrants maintenance of
porous structure and low interfacial  tension towards aqueous fluid is  necessary which
helps in disintegration by creating a hydrophilic network around the drug particles. The
wicking and swelling process of disintegration is shown in Fig. 1.1.
    WICKING         SWELLING
Fig.no.2. Disintegration by wicking and swelling process
3. Due to disintegrating particle/particle repulsive forces
Another  mechanism of  disintegrants  attempts  to  explain the swelling of  tablet
made with„ nonswellable’ disintegrants. Guyot-Hermannhas proposed a particle repulsion
theory based on the observation that  nonswelling particle  also cause disintegration of
tablets. The repulsive forces between particles are the mechanism of disintegration and
water is required for it. Researchers found that repulsion is secondary to wicking.
4. Due to deformation
During  tablet  compression,  disintegrated  particles  get  deformed  and  these
deformed  particles  get  into  their  normal  structure  when  they  come  in  contact  with
aqueous media or water. Occasionally, the swelling capacity of starch was improved when
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granules  were  extensively deformed during  compression.  This  increase  in  size  of  the
deformed particles produces a break up of the tablet. This may be a mechanism of starch
and has only recently begun to be studied. Disintegration of tablets by deformation and
repulsion is shown in Figure 3.
DEFORMATION REPULSION
Fig.no.3. Disintegration by deformation and repulsion process
(h) Sugar-based Excipients
Sorbitol, mannitol, dextrose, xylitol, fructose, maltose, isomalt and polydextrose
have been used as bulking agents. Because of their high aqueous solubility and sweetness,
which impart a pleasing mouth feel and good taste masking, nearly all formulations for
rapidly dissolving tablets contain sugar based materials.12
                                
Table No. 1  List of super disintegrants
Superdisintegrants Example
Mechanism of
Action
Special comment
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Crosscarmellose® Crosslinked Swells 4-8 folds Swells in two
Ac-Di-Sol® Cellulose in < 10 seconds, dimensions, used for
Nymce ZSX® acts by swelling direct compression
Primellose®Solutab® And or granulation
Vivasol®L-HPC wicking both
Crospovidone Crosslinked Swells very little Water insoluble and
Crospovidone M® PVP and returns to spongy in nature so
Kollidon® original size after get porous tablet
Polyplasdone Compression
but act by
capillary action
Sodium starch Crosslinked Swells 7-12 folds Swells in three
Glycolate Starch in < 30 seconds dimensions and high
Explotab® level serve as sustain
Primogel release matrix
Alginic acid NF Crosslinked Rapid swelling in Promote
Satialgine® alginic acid aqueous medium Disintegration
or wicking action in both dry or wet
Granulation
Soy polysaccharides Natural  Does not contain any
Emcosoy® superdisintegrant starch or sugar, used
In
nutritional products
Calcium silicate Wicking action Highly porous, 20-
40%
 (i)  Using acid treated yeast cell wall
Natural  materials  should  be  useful  as  pharmaceutical  additives  from  the
perspective  of  resource  utilization  and  safety.  Acidified  brewers’ yeast ce (AYC) has
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been examined with respect to novel applications as it can be used as an aqueous coating
material  for  tablets  and  granules.  In  accordance  with  these  properties  of  AYC,  AYC
maintains  the  baggy  structure  of  the  original  yeast.  In  water,  AYC  is  dispersed  as
independent particles with a surface hydrogel layer. Water is included within the structure
unlike other polymers.
(j) Using hydroxyl waxy binders
This  work  describes  a  new  approach  to  prepare  fast  dissolving  tablets  with
sufficient  mechanical  integrity,  involving  the  use  of  a  hydrophilic  waxy  binder
(Superpolystate©, PEG-6-stearate). So it  will not only act as a binder and increase the
physical resistance of tablets but will also help the disintegration of the tablets as it melts
in the mouth and solublises rapidly leaving no residues.
(k) Melt granulation technique
Melt granulation is  a process by which pharmaceutical  powders are efficiently
agglomerated by the use of a binder which can be a molten liquid, a solid or a solid that
melts during the process. For accomplishing this process, apparatus of choice are the high
shear  mixers,  where the product temperature is  raised above the melting point  of the
binder either by a heating jacket or when the impeller speed is high enough, by the heat of
friction generated by the impeller blades.
(l)  Cotton candy process
The cotton candy process is also known as the candy floss process and forms the
basis of the technologies such as Flash dose (Fuisz technology). An ODT is formed using
a  candy  floss  or  shear  from  matrix  and  the  matrix  is  formed  from  saccharides  or
polysaccharides processed into amorphous floss by a simultaneous action of flash melting
and centrifugal force. The matrix is then partially recrystallised to provide a compound
with good flow properties and compressibility. The candy floss can then be milled and
blended with active ingredients and other excipients and subsequently.
(m) Suspension spray coating method
To obtain rapid disintegration granules (RDGs), a saccharide, such as trehalose,
mannitol, or lactose, was spray coated with a suspension of corn starch using a fluidized-
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bed granulator (suspension method). As an additional disintegrant,  crospovidone, light
anhydrous silicic acid or hydroxy propyl starch was also included in the suspension.14
PATENTED TECHNOLOGIES FOR  ORODISPERSIBLE TABLETS
 Zydis technology
Zydis, the best known of the fast dissolving/disintegrating tablet preparations, was
the first marketed new technology tablet. The tablet dissolves in the mouth within seconds
after  placement  on  the  tongue.  Thirteen  products  are  currently  available  using  Zydis
technology.  In  the  U.S.,  they  include:  Claritin  Reditab,  Dimetapp  Quick  Dissolve,
Feldene  Melt,  Maxalt-MLT,  Pepcid  RPD,  Zofran  ODT  and  Zyprexa  Zydis.  On  the
worldwide  market,  other  Zydis  formulations  are  available  for  oxazepam,  lorazepam,
loperamide and enalapril.
A Zydis tablet is produced by lyophilizing or freeze drying the drug in a matrix
usually consisting of gelatin. The product is very lightweight and fragile, and must be
dispensed in a special blister pack. Patients should be advised not to push the tablets
through the foil  film,  but  instead peel  the film back  to  release the tablet.  The Zydis
product is made to dissolve in the tongue in 2-3 seconds.The zydius formulation is also
self-preserving because the final water concentration in the freeze-dried product is too
low to allow for microbial growth. The Zydis formulation utilizes flavors and sweeteners
to optimize the taste of the dosage form. In addition, it utilizes microencapsulation with
specialized polymers or complexation with ion exchange resins to mask the bitter tasting
drug. The combination of lyophilization and taste masking creates a product that is both
pleasing to the eye and also to the senses of taste and touch.
 DuraSolv Technology
DuraSolv  is  Cima's  second-generation  fast  dissolving  tablet  formulation.
DuraSolv product is thus produced in a fashion similar to OraSolv; DuraSolv has much
higher  mechanical  strength  than  its  predecessor  due  to  the  use  of  higher  compaction
pressures during tableting. The DuraSolv product is thus produced in a faster and more
cost-effective manner. DuraSolv is so durable that it can be packaged in either traditional
blister packaging or vials.
The newest DuraSolv formulation, NuLev, is actually dispensed in a conventional
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stock  bottle.  Pharmacists  are  advised  to  take  care  when  dispensing  such  DuraSolv
formulations from stock bottles to ensure they are not exposed to high levels of moisture
or humidity.
 OraSolv Technology
OraSolv was Cima's first fast-dissolving/disintegrating dosage form. The Ora Solv
technology,  unlike Zydis,  disperses in the saliva with the aid of  almost  imperceptible
effervescence. The OraSolv technology is best described as a fast-disintegrating tablet;
the tablet matrix dissolves in less than one minute, leaving coated drug powder. The taste-
masking associated with the Ora Solv formulation is two-fold.The unpleasant flavour of a
drug is not merely counteract by sweeteners or flavors; both coating the drug powder and
effervescence are means of taste-masking in OraSolv. This technology is frequently used
to develop over-the-counter  formulations.  An advantage that  goes  along with the low
degree of compaction of OraSolv is that the particle coating used for taste masking is not
compromised  by fracture  during  processing.  The  major  disadvantage  of  the  OraSolv
formulations,  its  mechanical  strength.  The  OraSolv  tablet  has  the  appearance  of  a
traditional compressed tablet. However, the OraSolv tablets are only lightly compressed,
yielding a weaker and more brittle tablet in comparison with conventional tablets.
 Flashdose technology
Flash dose tablets  consist  of  self-binding   shear   form   matrix  Shear  form
matrices are prepared by flash heat processing and are of two types:
• Single floss or Unifloss, consisting of a carrier, and two or more
sugar alcohols, of which one is xylitol. 
• Dual  floss consists  of  a  first  shear  f  contains  a  carrier  and  at  least  one sugar
alcohol  generally  sorbitol)  and  a  second  shear  form  binder  matrix    “binder
floss”,   contains
In  flash  heat  process,  the  feed  stock  (carbohydrates  including  sugars  and
polysaccharides) is  simultaneously subjected to centrifugal  force and to a temperature
gradient,  resulting  in  discrete  fibers.  The  preformed  matrices  obtained  are  partially
crystallized and have good self-binding and flow properties. The so formed matrices are
complex  crystalline  structures  with  high  specific  surface  area  and  result  in  rapid
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dissolution rate of the drug. Flash dose tablets are soft, friable and hygroscopic dosage
forms, which require specialized packaging.
 WOW tab technology
WOW tab technology is patented by Yamanouchi Pharmaceutical WOW means
“without  water”.  The  active  ingredient  is  mixed  with  a  low mouldability  saccharide
(e.g. lactose, mannitol) and granulated with a high mouldability saccharide  (e.g. maltose,
sorbitol) and  compressed into tablets. The WOWTAB product dissolves quickly in 15
seconds or less. The WOW in WOWTAB signifies the tablet is to be given without water.
Two WOWTAB formulations currently on the U.S. market are Benadryl Allergy & Sinus
FASTMELT and Children's Benadryl Allergy & Cold FASTMELT.
 Flashtab technology
The Flashtab technology is yet  another fast dissolving/disintegrating oral tablet
formulation. It utilizes most of the same excipients as in conventional compressed tablets.
A disintegrating agent and a swelling agent are used in combination with coated drug
particles in this formulation to produce a tablet that disintegrates in the mouth in less than
one minute.
 Frosta technology
Akina  patents  this  technology.  It  utilizes  the  concept  of  formulating  plastic
granules  and  compressing  them  at  low  pressure  to  produce  strong  tablets  with  high
porosity.  Plastic  granules  composed  of  porous  and  plastic  material,  water  penetration
enhancer, and binder. The process involves mixing the porous plastic material with water
penetration  enhancer  followed  by granulating  with  binder.  The  tablets  obtained  have
excellent hardness and rapid disintegration time ranging from 15 to 30 seconds depending
on the size of the tablet.
 LYOC Technology
It is patented by PHARMALYOC. Oil in water emulsion is prepared and
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placed directly in to blister cavities followed by freeze drying. Non- homogeneity
during  freeze  drying  is  avoided  by  incorporating  inert  filler  to  increase  the
viscosity finally the sedimentation. High proportion of filler reduces porosity of
tablets due to which disintegration is lowered.
 QUICKSOLV technology
This  technology  is  patented  by Janssen  Pharmaceutical.  It  utilizes  two
solvents  in  formulating  a  matrix,  which  disintegrates  instantly.  Methodology
includes dissolving matrix components in water and the solution or dispersion is
frozen.  Then  dry  the  matrix  by  removing  water  using  an  excess  of  alcohol
(solvent extraction). Thus the product formed has uniform porosity and adequate
strength for handling.
 AdvaTab Technology
AdvaTab tablets disintegrate rapidly in the mouth, typically in less than 30 
seconds, to allow for convenient oral drug administration without water. These tablets are 
especially suited to those patients that experience difficulty in swallowing capsules and 
tablets. AdvaTab is distinct from other ODT technologies as it can be combined with 
Eurand’s complimentarytechnologieslikeits world particle leading Microcaps® taste 
masking technology and its Diffucaps®, controlled release technology.
 OraQuick technology 
The OraQuick fast-dissolving/disintegrating tablet formulation utilizes a patented
taste masking technology. KV Pharmaceutical claims its microsphere technology known
as Micro Mask, has superior mouth feel over taste masking alternative. The taste masking
process  doesnot  utilize  solvents  of  any  kind  and  therefore  leads  to  faster  and  more
efficient production. OraQuick claims quick dissolution in a matter of seconds, with good
taste-masking. There are no products using the OraQuick technology currently on the
market,  but  KV  Pharmaceutical  has  products  in  development  such  as  analgesics,
scheduled drugs, cough and cold, psychotropics and anti-infectives.
Advantol™   200
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Advantol™  200  is  a  excipients  directly  system  offering  compressi"  Soft-Melt"
functionality  and  specially  formulated  for  nutraceutical  applications.  SPI  Pharma’s
Advantol  platform  uses  proprietary  co-processing  technology.  Advantol  requires  no
special  manufacturing  equipment  or  tooling.  Advantol  formulations  utilize  a  standard
rotary tablet press with standard tooling under normal tableting temperature and humidity
conditions to make robust-melt”let“soft.15,17,19.
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Punit.B.Parejiya  et  al., (2011),  designed  the  validation  and  development  of  UV
spectrophotometric method for determination of UV spectrophotometric method for the
determination of Milnacipran in band pharmaceutical dosage bulk and Pharmaceutical
dosage form.A new,rapid and simple and sensitive spectrophotometric method has been
developed  for  the  determination  of  Milnacipran.The  linerarity  was  observed  in  the
concentration  range  of  2-45µg/m¯ 1.Absorbance  was  determined  at  220nm
wavelength.Results  of analysis were validated statistically and by record studies.The
proposed  method  was  found  accurate,reproducible  and  economical  for  the  routine
analysis of Milnacipran in bulk and pharmaceutical formulations21.
Anupama Kalia A et al., (2009), prepared mouth dissolving tablets of oxcabazepine
using two  different technologies, direct compression method and solid dispersion
technology. Tablets produced by direct compression method contain crospovidone as a
superdisintegrant and aspartame as a sweetener. Solid dispersions of oxcarbazepine with
polyvinyllpyrrolidone K-30 and polyethylene glycol  6000 in different weight  ratios
were  prepared with a view  to  increase its  water solubility. Oxcarbazepine solid
dispersions  with polyvinylpyrrolidone K-30 in 1:2 ratios  of drug: carrier showed
maximum drug release and hence, compressed along with other excipients into mouth
dissolving tablet.  The results compared for both  the  technologies  showed that  the
oxcarbazepine tablets prepared using solid dispersion technology was found to have
good  technological  properties  and  satisfying and  reproducible  drug  dissolution
profiles22.
Vishal  Dhiman  et.al,.(2012),formulated  and  evaluated  the  fast  dissolving  tablets  of
Telmisartan by using Superdisintegrants such as crosscarmellose sodium,Microcrystalline
cellulose and sodium starch glycolate.The tablets were prepared by direct compression
method and the prepared blend were evaluated fot their physiochemical properties and in-
vitro dissolution study.The evaluation studies were performed such as weight variation,
thickness,  Hardness,  Disintegration  time,  Wetting  time  and  In-vitro  drug  release.The
disintegration  time  of  fast  dissolving  tablets  were  increased  by  the  addition  of
concentration of superdisintegrants23.
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Mihir Patel et al.(2012).,  formulated the Olnazipane orally disintegrating tablet  using
Wet  granulation  Technique  using  different  superdisintegrants  such  as  SodiumStarch
Glycolate,CrospovidoneXL,Crosscarmellose sodium and Kyron T-314.kyron (2%) having
least disintegration time.32 randomized full factorial design was adopted to optimize the
variable.The amount of sublimating agent,menthol and the amount of Kyron T-134 were
selected as independent variables.Disintegration time and the percentage friability were
selected as dependent variable.On increasing the concentration of menthol and Kyron T-
134 decreases the disintegration time and shows better drug release.The stability study of
selected batches were carried out at room temperature and at 40 ± 2°C/75 % BH for 3
months24.
Sree Giri Prasad et.al(2012)., prepared and evaluated the orodispersible tablets of 
stavudine by direct compression technique.The purpose of this study was to optimize the 
formulation of Orodispersible tablets of stavudine  using different superdisintegrants such
as Sodium starch glycloate,Crospovidone,Crosscarmelosesodium and kollidon CLM) at 
different concentrations.The formulations were evaluated Tablet weight variation  
,contentuniformity.hardness,friability,wetting time dispersion time,drug content and 
invitro release also been studied.All the formulations showed satisfactory mechanical 
strength and the tablet containing kollodion CLM (20%) showed excellent invitro 
dispersion time and drug release compared to other formulations.The results revealed that
the tablets containing 20% kollidon  CLM  shows shorter dispersion time with maximum 
drug release25.
G.Nagaprakash  et  al.,(2009) formulated  rapidly  disintegrating  oral  tablets  of
Valdecoxib. For formulation, they used sodium starchglycolate, crosscarmellose sodium
and crospovidone as superdisintegrants and mannitol as diluent. The formulated tablets
were evaluated for  hardness, friability, weight variation, disintegration time and in-vitro
dissolution studies. Finally it was concluded that the fast dissolving tablets of the poorly
soluble  drug  can  be  made  by  direct  compression  technique  using  selective
superdisintegrants26
Jain  CP  et  al.,(2009)  prepared  fast  dissolving  tablets  of  Valsartan  using  different
superdisintegrants  by  direct  compression  method,  evaluated  for  physicochemical
properties and  in vitro dissolution. Effect of disintegrant on disintegration behavior of
tablet in artificial saliva, pH 5.8 was evaluated. Wetting time of formulations containing
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crospovidone was least and tablets showed fastest disintegration. The drug release from
FDTs increased with increasing concentration of superdisintegrants and was found to be
highest with formulations containing crospovidone27
KY Desale,et  al  .,(2012)  Formulated and evaluated  Fexofenadine Hydrochloride fast
dissolving tablet using  various Superdisintegrants by using direct compression method.In
this  study  various  range  of  superdisintegrants  in  their  different  concentrations  were
used.Superdisintegrants used were crosscarmelose sodium,crospovidone and kyron T-134.
It was observed that kyron with concentration range of 1,2,3 %w/w shows drug release
rate of 95.58%,96.32% and 97.46% in 20 minutes.This indicates that as the concentration
increases the disintegration time also increases28
Parmar RB  et al.,(2009) worked on formulation and evaluation of Domperidone fast
dissolving tablets by using superdisintegrants such as Avicel PH 102 and sodium starch
glycolate by direct compression.All the formulations were evaluated for characteristics
such as hardness,friability,disintegration time and dissolution rate and they found a good
hardness of 3kg/cm2, disintegration time of 27 seconds and in vitro drug release is 95%
within  30  minutes  as  compared  to  the  marketed  product,  which  gives  quick  release
fromemesis29
 Sanjay  Modi  et.al., (2012),Formulated,development  and  optimization  of  controlled
porosity osmotic pump tablets of Milnacipran Hydrochloride.The CPOP tablets contains
pore former,the effect of different variables like ratio of drug to osmogen .% weight gain
and level of pore former in the coating solution .The in vitro drug release is studied using
23 factorial design.The results shows that the drug release rate increases because of the
increased  water  uptake.Drug  release  was  inversely proportional  to  membrane  weight
gain.30
Kulkarni Maushumi et.al studied on the formulation and evaluation of orodispersible
tablets of ornidazole. In this, they prepared spray dried microspheres of ornidazole and
formulate them into orodispersible tablets.Microsphees were formulated using polymer
Polyvinyl pyrrolidone and combinations of PVP-Mannitol by spray drying technique at
different  ratios.The  work  also  describes  the  preparation  of  orodispersible  tablet  of
ornidazole  by  using  superdisintegrants.The  spray  dried  microspheres  depicted  taste
masking ability,and the orodispersible tablet of ornidazole shows excellent release and
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disintegration profile31
Parikh Bhavik et al. prepared and evaluated fast dissolving tablets of Lornoxicam fast
dissolving  tablet  by sublimation  and  effervescent  method using various  excipients  in
different concentrations. crospovidone (5%) was used as superdisintegrants. The prepared
formulations  were evaluated for  hardness,  friability,  disintegration time,  wetting time,
drug  content  and  invitro  drug  release  studies.  Fast  dissolving  tablets  prepared  by
sublimation  method  with  10%  methanol  and  effervescent  method  with  15%  sodium
carbonate and 5 % citic acid showed  drug release of 98.95% in 6 minutes 32.
Swamy PV et al.,  designed Orodispersible tablets of Meloxicam with a view to enhance
patient  compliance.  A combination of  superdisintegrants i.e.,  sodium starch glycolate-
crospovidone and sodium starch glycolate-croscarmellose sodium were used with directly
compressible  mannitol  to  enhance  mouth  feel.  Based  on  in  vitro dispersion  time
(approximately 10 sec), two formulations (one from each batch) were tested for in vitro
drug release pattern (in  pH 6.8 phosphate buffer),  short  term stability (at  45°C for  3
weeks) and drug-excipients interaction (IR spectroscopy). Among the two formulations,
the formulation containing 2% sodium starch glycolate and 1.5% crosscarmellose sodium
was found to be better formulation 33.
Patel  et al., 62 (2010),  prepared mouth dissolving tablets of Diazepam using different
types  of  superdisintegrants  Ac-di-sol,  sodium  starch  glycolate  and  crospovidone  and
different  types  of  subliming  agents  camphor  and  ammonium bicarbonate  at  different
concentrations  and  two  methods  of  tablets  preparations  (wet  granulation  and  direct
compression  methods).  The  formulations  were  evaluated  for  flow properties,  wetting
time, hardness, friability, content uniformity,  in vivo disintegration time, release profiles
and buccal  absorption tests.  All  formulations  showed satisfactory mechanical  strength
except  formulation  which  contains  camphor  and  formulation  which  was  prepared  by
direct compression method. The results revealed that the tablets containing crospovidone
as a superdisintegrant had good dissolution profile with shortest disintegration time 34.
PathikkumarJM  et.al  prepared  orally  disintegrating  tablet  of  Dicyclomine
Hydrochloride by superdisintegrant addition method .Eight formulations were prepared
using Croscarmellose sodium,Sodium Starch Glycolate,Crospovidone and Indion resin
-414  as  superdisintegrants  each  in  concentrations  of  2%  and  5%.The  prepared
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formulations were assessed for in process parameters and finished product parameters.
Formulation  with crospovidone were identified as optimized formulation amongst all the
formulations developed for oral disintegrating tablets35.
Goyani  et.al.(2012),evaluated  the  prepared  orally  disintegrating  tablets  of  Meclizine
Hydrochloride using different  disintegrating agents such  as  Sodium Starch  Glycolate,
croscarmellose sodium,crospovidone in different  concentration  by direct  compression
method.The formulated batches were characterized by different physical parameters.The
study revealed that the formulation containing crospovidone as disintegrants shows faster
disintegration compared to others36.
Sanjay, et al., (2010) Fast dissolving tablets of Terbutaline sulphate were prepared using
various concentration of polmers such as Microcrystalline cellulose and sodium starch
glycolate,  by  direct  compression  method..  Tablets  were  evaluated  for  uniformity  of
weight,  hardness,  friability,  content  uniformity,  wetting  time,  dispersion  time,
disintegration time and in-vitro drug release. The results were complines with the official
specifications  within the limits.Invitro  dissolution data  shows that  the  formulation F3
contaning sodium starch glycolate alone released 95.2 % of drug within 10 minutes 37.
Jacob, et al.,   (2007) co-processed particles of microcrystalline cellulose and mannitol
were fabricated by spray drying technique to be used as direct compression excipient in
fast dissolving tablet formulation. Microcrystalline cellulose passed through sieve no:80
having  volumetric  mean  diameter  (d50)  of  28.35  µm  was  used  to  form  composite
particles with  powdered mannitol which was previously passed through sieve no :80 in
various  mixing  ratios.  The  composite  particles  were  evaluated  for  their  powder  and
compression properties38.
Abdul  Jaleel  et  al.,  (2010)   The  research  was  to  enhance  the  dissolution  of  orally
disintegrated  tablets  of  loratadine.  Orodispersible  tablets  of  loratadine  were  prepared
using different types and concentrations of superdisintegrant (Ac-Di-Sol, sodium starch
glycolate, and crospovidone (CP)) using direct compression method. The drug is poorly
water soluble therefore to enhance the solubility and release of drug, solid dispersion of
drug with PVP K30 was prepared by solvent evaporation method. The formulas were
evaluated for flow properties,  wetting time, hardness,  friability,  content uniformity,  in
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vivo  disintegration  time  (DT),  release  profiles,  and  buccal  absorption  tests.  All
formulations showed satisfactory mechanical strength and friability. The results revealed
that the tablets containing CP as a superdisintegrant have good dissolution profile with
shortest DT39. 
V.Anand et.al(2007)  prepared taste-masked orally disintegrating tablets of Prednisolone
by incorporation of microspheres in the tablets by solvent evaporation method..Tablets
were  prepared  by direct  compression  method containing microspheres,were  evaluated
with regrad to crushing strength,friability,disintegration time ,drug content and in vitro
drug release and .taste evaluation studies confirmed that micospheres of PDL having a
drug to polymer ratio 1.10 are tasteless and these wee further used for formulation in
ODTs.Effective  taste  masking  was  achieved  for  PDL  using  the  technique  of
microencapsulation  and  ODTs  of  acceptable  characteristics  were  obtained  by
disintegrationaddition and direct compression method40.
Garg  Ashish et.al(2013)  Taste  masking  and   formulation   and  evaluation  of  mouth
dissolving  tablets  of  Levocetrizine  dihydrochloride.Results  shows  that  effective  taste
masking is achieved for Levocetrizine hydrochloride by preparing drug resin complex
using Kyron T-134 The tablets are evaluated for the drug content,weight variation, and
water  absorption  ratio,wetting  time,invitro  disintegration  ,hardness,friability,thickness
uniformity and in-vitro dissolution41.
 Suresh vk et al.(2010) studied the effect of superdisintegrant on the formulation of taste
masked  fast  disintegrating  Lisnopril  Tablets.superdisintegrants  such  as  crospovidone
crosscarmellose  sodium  were  used..Tablets  were  evaluated  for  the  weight  variation
,thickness,disintegration time ,dissolution time. Tablets containing crospovidone exhibit
quick disintegration time than tablets containing croscarmellosesodium42
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Antidepressant is a Psychiatric medication used for alleviating major depression.
Depression is  a state  of low mood and aversion to activity that  can affect  a person’s
thought, behaviour feelings and sense of well being. The major cause of depression is an
inadequate amount of serotonin and altering levels of neurotransmitters.
Milnacipran Hydrochloride is a potential fourth generation antidepressant drug .It
is a selective norepinerphine serotonin reuptake inhibitor.It inhibit nor epinerphine uptake
with greater potency than serotonin.
Milnacipran  Hydrochloride  is  indicated  for  the  treatment  of  major  depressive
disorder.In  January 2009,approved  FDA Milnacipran  Hydrochloride  (under  the  brand
name Savella) only for the treatment of fibromyalagia, making it is the third medication
approved for this purpose in the united states. Milnacipran Hydrochloride is available as
conventional dosage forms such as tablets (12.5, 25, 50 and 100 mg) and as capsules (25,
50 and 100 mg). Milnacipran Hydrochloride is available in India as tablets and capsules
from leading pharmaceutical companies such as Ranbaxy, Intas, Torrent, and Sun pharma
But Milnacipran Hydrochloride is not available as orally disintegrating tablet in India as
well as in US market.
           In case of major depressive disorders and in fibromyalgia, patients having  jaw and
facial  tenderness,  impared  concentration,  troubled  in  thinking,  difficulty  in
remembering.The  treatment  of  above  mentioned  condition  requires  continuous  drug
therapy and patient compliance.
         In order to treat the disease effectively and to improve the patient complaince, the
Milnacipran Hydrochloride was planned to prepare as an orodispersible tablets. These
tablets disintegrates quickly in the saliva (without the need of water), within a matter of
seconds in oral cavity. Thus it helps to achieve rapid onset of action and improves patient
compliance. These are all the salient features of selecting Milnacipran Hydrochloride as
an orodispersible tablets.
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OBJECTIVE
The main objective of present work is to prepare the orally disintegrating tablets
of Milnacipran Hydrochloride using different super disintegrants.
PLAN OF WORK
PREFORMULATION STUDY
   Organoleptic evaluation of API
   Analytical Evaluation of API
 FTIR  spectroscopic Analysis
 UV spectroscopic Analysis
 Formulation Development
 Selection of  Excipients 
 Preparation of blend
 Direct compression of orally Disintegrating Tablets
 Evaluation of blend for bulk characterisation
   Evaluation of formulation
 Weight variation
 Thickness
 Crushing Strength
 Friability
 Disintegration Time
 Dispersion time
 Water absorption ratio
 Wetting time
 Drug Content
 Uniformity of  Dosage forms
 Invitro Dissolution study 
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 All the chemicals and other materials used in the present investigation were the
best grade available in the laboratory and supplied by the manufactures.
                               
Table .No.2  List of  Materials Used   
             Raw materials                    Source
Milnacipran Hydrochloride Par Parmaceuticals, Chennai.
Mannitol (Pearlitol SD 200) Par Pharmaceuticals , Chennai.
Kyron T-314 (Pollacrillin Potassium) Corel Pharma Chem, Ahmedabad.
Crosscarmellose sodium Par Pharmaceutical, Chennai.
Sodium Starch Glycolate Par Pharmaceuticals, Chennai.
Crospovidone Par Pharmaceuticals, Chennai.
Aerosil 200 (Collodial Silicon Dioxide) Merck Specialities Private limited. 
Mumbai
Povidone Par Pharmaceuticals ,Chennai.
Magnesium Stearate Vama Pharma, Nagpur.
Sucralose SD fine chem, Mumbai
Vanilla flavour SD fine chem, Mumbai
Table .No.3      list of equipments used
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Instruments Suppliers
Electronic Weighing Balance Shimadzu philippines manufacturing, 
Japan(243IZ)
Tablet compression machine Cemach machineries LTD ,Ahamedabad
Vernier Caliper Mitutoyo,Absolute,Digimatic
 Tablet Hardness tester Praveen enterprises
Friability test apparatus PSM industries, Mumbai
Sieves Jayanath Test Sieves
Dissolution test apparatus 
(disso2000)(USP)
Labindia instruments PVT LTD,Mumbai
UV-Visible spectrophotometer Systronic 118
 T.A.X.T plus Texture Analyser Stable Micro System,U.K
Disintegration tester USP Electrolab  Mod
Dissolution Apparatus USP-2-DS-8000 Manufactured by
Electrolab, Mumbai
FTIR spectrophotometer Perkin- Elmer Lambda 40P
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DRUG PROFILE43,44,45
Drug Name : Milnacipran Hydrochloride
Chemical Name : (±)-[1R(s),2s(R)]-2-(amino methyl)-N,N-diethyl-
phenylcyclopropane carboxamide hydrochloride.
Molecular Formula : C15H22N20.HCl
Molecular Weight : 282.81
CAS Register Number : 101152-94-7
Category ; Major depressive disorder
                                                            Management of fibromyalagia
Descripition              : White to off white crystalline powder
Solubility                 : freely soluable inwater,methanol,ethanol,chloroform
                                                            and  methylchloride. Sparingly soluable in                
                                                             diethylether
BCS Class                               :           Class I (Highly Soluable.Highly Permeable)
Melting Point          :   179°C
Storage                    :   Store at tightly closed container,protected from 
 moisture.
PKa Value                             :          9.83
Dose                        :           Initial dose on day 1 – 12.5 mg
                                               Day 2 and 3 – 12.5 mg twice daily
           Day 4 through 7  - 25 mg twice daily
After day 7 - 50 mg twice daily
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Structural Formula
Clinical pharmacology
Mechanism
The exact mechanism of the central pain inhibitory action of Milnacipran and its
ability to improve the symptoms of  fibromyalgia in humans are unknown. Preclinical
studies have shown that Milnacipran is a potent inhibitor of neuronal norepinephrine and
serotonin reuptake; Milnacipran inhibits norepinephrine uptake with approximately 3-fold
higher potency in vitro than serotonin without directly affecting the uptake of dopamine
or other neurotransmitters.  Milnacipran has no significant  affinity for  serotonergic (5-
HT1-7),  α-  and β-adrenergic,  muscarinic (M1-5),  histamine (H1-4),  dopamine (D1-5),
opiate,  benzodiazepine,  and  γ-aminobutyric  acid  (GABA)  receptors  in  vitro.
Pharmacologic  activity  at  these  receptors  is  hypothesized  to  be  associated  with  the
various anticholinergic, sedative, and cardiovascular effects seen with other psychotropic
drugs. Milnacipran has no significant affinity for Ca++, K+, Na+ and Cl– channels and does
not  inhibit  the  activity  of  human  monoamine  oxidases  (MAO-A and  MAO-B)  or
acetylcholinesterase. 
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Pharmacokinetics
Milnacipran  is  well  absorbed  after  oral  administration  with  an  absolute
bioavailability of  approximately 85% to 90%.  The exposure to  milnacipran  increased
proportionally within the therapeutic dose range. It is excreted predominantly unchanged
in urine (55%) and has a terminal elimination half-life of about 6 to 8 hours. Steady-state
levels are reached within 36 to 48 hours and can be predicted from single-dose data. The
active enantiomer, d-milnacipran, has a longer elimination half-life (8-10 hours) than the
l-enantiomer (4-6 hours). There is no interconversion between the enantiomers.
Absorption and Distribution
Milnacipran  is  absorbed  following  oral  administration  with  maximum
concentrations (Cmax) reached within 2 to 4 hours post dose. Absorption of the drug  is
not affected by food. The absolute bioavailability is  approximately 85% to 90%. The
mean  volume  of  distribution  of  Milnacipran  following  a  single  intravenous  dose  to
healthy subjects is approximately 400 L.
Plasma protein binding is 13%.
Metabolism and Elimination
Hepatic metabolism of Milnacipran occurs via glucuronidation. No involvement
of CYP450 isozymes or active metabolites found.
Milnacipran  and  its  metabolites  are  eliminated  primarily  by  renal  excretion.
Following oral administration of  14C-milnacipran hydrochloride, approximately 55% of
the dose was excreted in urine as unchanged Milnacipran (24% as l-Milnacipran and 31%
as d-Milnacipran). The l-Milnacipran carbamoyl-O-glucuronide was the major metabolite
excreted in urine and accounted for approximately 17% of the dose; approximately 2% of
the  dose  was  excreted  in  urine  as  d-Milnacipran  carbamoyl-O-glucuronide.
Approximately 8% of  the  dose  was  excreted  in  urine  as  the  N-desethyl  Milnacipran
metabolite.
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Toxicity Data
LD50, oral, rat: 213 mg/kg. The most frequently occurring adverse reactions ( ≥
5% and greater than placebo) were nausea, headache, constipation, dizziness, insomnia,
hot  flush,  hyperhidrosis,  vomiting,  palpitations,  heart  rate  increased,  dry  mouth,  and
hypertension.
Half Life 
The terminal elimination half-life, when given to healthy subjects is 6-8 hours.
When given to severe renal impairment patients is 7 - 10 hours. The active enantiomer, d-
Milnacipran, has a longer elimination half-life (8-10 hours) than the l-enantiomer (4-6
hours). 
Therapeutic Indications 
Milnacipran  Hydrochloride  is  used  in  major  depressive  disorder  and  in
fibromyalagia.
Contraindications
Contraindicated in patients with known hypersensitivity to Milnacipran,  during
lactaction,  pregnancy,and  in  prostatic  hypertrophy  and  in  genitor-urinary  disorders.
milnacipran hydrochloride is also contraindicated on association with non-selective MAO
inhibitors, digitalis and with 5HT agonists.
Interactions
Milnacipran  Hydrochloride  with  5-HT  receptor  agonists  causes  coronary
vasoconstriction  with  risk  of  angina  pectoris  and  myocardial  infaraction,with
Epinephrine,Norepinephrine  hypertensive  possible  cardiac  arrthymia  may  occur.
Milnacipran  Hydrochloride  antagonises  the  hypertensive  action  of  clonidine.With
Digitalis,Milnacipran hydrochloride increases the hemodynamic actions.
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Adverse Effects39,40
Adverse  effects  include  Nausea,  vomiting,  Dry  mouth,  Constipation.  Loss  of
appetie,  Dizziness,  Increased  sweating,  Headache,  Hot  flashrs,  palpitations,  migrane,
tachycardia
EXCIPENT PROFILE
MANNITOL46
 Synonyms:   
Cordycepic acid, manna sugar, D-mannite, mannite
Chemical Structure:
                     
Description:
 Mannitol is D-mannitol. It  is a hexahydric alcohol related to
mannose and is isomeric with sorbitol.
 Mannitol  occurs  as  a  white,  odorless,  crystalline  powder  or  free-flowing
granules. It  has a sweet taste, approximately as sweet as glucose and half as
sweet as sucrose, and imparts a cooling sensation in the mouth.               
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Chemical Name :   D - Mannitol 
Empirical Formula :   C6 H14 O6           
Molecular Weight :   182.17
Functional Category:                      
Sweetening agent,  tablet and capsule diluents,  tonicity agent,  vehicle (bulking
agent) for lyophilized preparations.
Application in Pharmaceutical Formulation: 
Mannitol is widely used in pharmaceutical formulations and food products.
 In pharmaceutical preparations it is primarily used as a diluents (10-90%
w/w) in tablet formulations.
 Mannitol  is  commonly  used  as  an  excipient  in  the  manufactures  of
chewable  tablet  formulations  because  of  its  negative  heat  of  solution,
sweetness, and ‘mouth feel’.                                               
Stability and Storage Condition:
Mannitol is stable in the dry state and in aqueous solutions. In solution, mannitol
is not attacked by cold, dilute acids or alkalis, not by atmospheric oxygen in the absence
of catalysts.
Incompatibilities: 
Mannitol solutions, 20% w/v or stronger, may be salted out by potassium chloride
or  sodium chloride.
Safety: 
After intravenous injection, mannitol is not metabolized to any  appreciable extent
and is minimally reabsorbed by the rental tubule, about  80% of a dosage being excreted
in the urine in 3 hours..22
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CROSS CARMELLOSE SODIUM46
Non proprietary names:
BP : cross caramelise sodium
Ph EUR : carmellose natricum conexum
USP NF : cross caramelise sodium
Synonym:
A cross-linked polymer of Carboxymethylcellulose sodium; Ac-Di-Sol; Explocel
Chemical Name and CAS registry number:
Cellulose, carboxymethyl ether, sodium salt, cross linked [74811-65-7]
Empirical formula molecular weight:
Crosscarmellose sodium is a cross linked polymer of carboxyl methyl cellulose
sodium.
Molecular Weight: 570.49 gm
Structural formula:
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Description:
Crosscarmollese sodium occurs as an order less, white or grayish white powder.
Crosscarmellose sodium is a cross linked polymer of carboxy methyl cellulose sodium.
Crosslinking makes it an insoluble, hydrophilic, highly absorbent material, resulting in
excellent  swelling  properties  and  its  unique  fibrous  nature  gives  it  excellent  water
wicking  capabilities.  Crosscarmellose  sodium  provides  superior  drug  dissolution  and
disintegration characteristics, thus improving bioavailability of formulations
Functional Category:
Use as a superdisintegrant  in pharmaceutical formulations
Stability and storage conditions :
 Crosscarmellose sodium is a stable though hygroscopic material.  It   should be
stored in a well-closed container in a cool, dry, place
CROSPOVIDONE39
 Non proprietary names:
BP : povidone
JP : povidone
Pheur : povi done
USP : povidone
Synonyms: 
           Crosspovidone, Crosspovidonum, Insolublepolyvinylpyrrolidine, Crosslinkedpvp,
kollidone
Description:
          Crospovidone is a water-insoluble synthetic cross-linked homo- polymer of  N-
vinyl-2-pyrrolidinone. It contains NLT 11.0% and NMT 12.8% of nitrogen (N), calculated
on the anhydrous basis.
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Chemical name:
1-Ethenyl-2-pyrrolidinone homopolymer
1-Vinyl-2-pyrrolidinone homopolymer
Empirical Formula and molecular weight:
(C6H9NO)n, 2500-3,000000
Structural formula:
Functional category:
Used  as  superdisintegrant dissolution  aid,  suspending  agent,  tablet  binder,  in
pharmaceutical formulations.
Applications in pharmaceutical formulation or technology:
            Although crospovidone is used in a variety of pharmaceutical formulations ,it is
primarily used in solid-dosage forms in tableting , Povidone solutions are used as binders
in wet-granulation process. Poll done is also added to powder blends in the dry form and
granulated  in  situ  by  the  addition  of  water  ,  alcohol  ,or  hydro  alcoholic  solutions  ,
povidone is used as a solubilizer in oral and parentral formulation and has been shown to
enhance dissolution of poorly soluble drugs from solid-dosage forms. Poll done solution
may also be used in coating agents.
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            Povidone is additionally used as a suspending, stabilizing, or viscosity .increasing
agent in number of topical agents
Typical Properties:
Acidity/alkalinity; PH=8.0-7.0(8% w/v aqueous solution)
Density (bulk):0.29-0.39 g/cm3 for povidone
Density (tapped):0.39-0.54 g/cm3 for povidone
Density (true): 1.180 g/cm3
Flowability:
20 g/s for povidone k-15
16 g/s for povidone k-29/32
Melting point: soften at 1500C
Moisture contents:
Povidone is very hygrosopic significant amount of moisture seing absorbed at low
relative humidities.
Solubility:
Freely  soluble  in  acids,  chloroform,  ethanol,  ketones,  methanol,  and  water;
practically insoluble in ether, hydrocarsons, and mineral oil.
In water the concentration of a solution is limited only by the viscosity of the solution,
which is a function of the k-value.
Stability and storage conditions:
Povidone darkens  to  some  extent  on  heating  at  150°C ,  with  a  reduction  in
aqueous solubility .it is stable to short cycle of heat exposure  around 110-130°C; steam
sterilization of an aqueous solution does not after its properties .aqueous solutions are
susceptible  to  mold  growth  and  consequently  require  the  addition  of  suitable
preservatives.
Povidone  may  be  stored  under  ordinary  conditions  without  undergoing
decomposition or degradation. However, since the powder is hygroscopic, it should be
stored in an airtight container in a cold dry place22,23
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KYRON T -13446 (Polacrillin potassium)
Nonproprietary Names USPNF : Polacirilin potassium
Synonyms:
Amberlite IRP-88;  methacrylic  acid polymer  with divinylben- zene, potassium
salt; polacrilinum kalii.
Chemical Name and CAS Registry Number
2-Methyl-2-propenoic   acid   polymer    with   divinylbenzene, potassium  salt
[39394-76-5]
Structural Formula
Functional Category
Tablet and capsule disintegrant.
Applications in Pharmaceutical Formulation or Technology
Polacrilin  potassium  is a  cation-exchange resin  used  in  oral pharmaceutical
formulations as a tablet disintegrant.(1–3%) Concentrations of 2–10%  w/w have been
used for this purpose although  2% w/w of polacrilin potassium  is usually sufficient.
Other   polacrilin   ion-exchange   resins   have   been   used   as excipients  to  stabilize
drugs,  to  mask  or  modify  the  taste  of drugs,   and   in  the  preparation  of  sustained-
release   dosage forms and drug carriers.
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Polacrilin   resins   are   also   used   in  the   analysis   and   manufacture  of
pharmaceuticals and food products.
Description
Polacrilin  potassium  occurs as a cream-colored, odorless  and tasteless,  free-
flowing  powder.   Aqueous  dispersions   have  a bitter taste.
Typical Properties
Density(bulk) :0.48 g/cm2 for Amberlite IRP-88
Density(tapped) : 0.62 g/cm2 for Amberlite IRP-88
Solubility : practically insoluable in water and most other liquids, although     
  polacrilin  resins swell rapidly when wetted.
SODIUM STARCH GLYCOLATE46,47
 Synonyms: Explotab, Primogel.
Structural formula:
           
                            
Non-proprietary Name: 
BP-Sodium starch glycolate, 
USPNF-Sodium starch glycolate
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Functional category : Tablet and capsule disintegrant.
Chemical names : Sodium carboxymethyl starch.
Solubility : Practically insoluble in water, sparingly soluble in ethanol
Incompatibilities : Incompatible with ascorbic acid.
Description:
Sodium starch glycolate is a white to off-white, odourless,   
tasteless, free flowing powder. It  consists of oval or spherical granules,  30-100 µm in
diamet some less spherical granules ranging from 10-35 µm in diameter.
Stability and storage conditions: 
It is a stable material. It should be stored in a well closed container to protect from
wide variations in humidity and temperature that may cause cracking.
Safet:
It is generally regarded as a non-toxic and non-irritant material. However, oral  
ingestion of large quantities may be harmful.
Applications:
As a disintegrant in tablet (wet granulation and direct compression) and capsule 
formulation in 2-8% concentration.
Stability and Storage conditions:
Polacirillin potassium and other polacrilin resins are stable to light ,air and heat up
to their maximum  temperature  Excessive  bledding can cause thermal decomposition of
the resins and yield one or more oxides of carbon,Nitrogen,sulfer and or amines
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POVIDONE46
Nonproprietary Names
BP : Povidone
JP : Povidone
PhEur : Povidonum 
USP : Povidone
Synonyms
poly [1-(2-oxo-1-pyrrolidinyl)ethylene]; polyvidone; polyvinylpyrrolidone; PVP; 1-vinyl-
2-pyrrolidinone polymer.
Chemical Name 
1-Ethenyl-2-pyrrolidinone homopolymer 
Empirical Formula 
(C6H9NO) n 
Functional Category
Disintegrant, dissolution aid, suspending agent and tablet binder.
Applications in Pharmaceutical Formulation or Technology
In  tableting,  Povidone is  used  as  binders  in  wet-granulation  processes  and  as
coating agents.
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Description
Povidone occurs  as  a  fine,  white  to  creamy-white  colored,  odorless  or  almost
odorless,  hygroscopic  powder and  freely  soluble  in  acids,  chloroform,  methanol,  and
water practically insoluble in ether, hydrocarbons and mineral oil.
Stability and Storage Conditions
The powder is hygroscopic; it should be stored in an airtight container in a cool,
dry place.
Incompatibilities
Povidone is compatible in solution with a wide range of inorganic salts, natural
and synthetic resins, and other chemicals. 
Safety
Povidone  may  be  regarded  as  nontoxic  since  it  is  not  absorbed  from  the
gastrointestinal tract or mucous membranes.
COLLOIDAL SILICON DIOXIDE (AEROSIL)46
Synonyms                  
Aerosil, Cab-O-Sil, colloidal silica, light anhydrous silicic acid, silicic anhydride,
Silicon dioxide fumed.            
Description:
Colloidal silicon dioxide is submicroscopic fumed silica with a particle size of
about  15nm.It  is  a  light,  loose,  bluish-white-colored,  odorless,  tasteless,  non-gritty
amorphous powder.
Chemical Name : Silica
Empirical Formula : SiO2            
Molecular Weight : 60.08       
Functional Category : Adsorbent, anti caking agent, glidant, tablet Disintegrant, 
viscosity-increasing agent.
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Application in Pharmaceutical Formulation:
 Colloidal silicon dioxide is widely used in pharmaceuticals, cosmetics, and
food products.
 Colloidal  silicon  dioxide  is  also  used  to  stabilize  emulsions  and  as  a
thyrotrophic  thickening  and  suspending  agent  in  gels  and  semisolid
preparations.
 Colloidal  silicon  dioxide  is  also  used  as  a  tablet  disintegrant  and as  an
adsorbent, dispersing agent for liquids in powders.
Stability and Storage Condition:
 Colloidal silicon dioxide is hygroscopic but adsorbs large quantities
of water without liquefying.
 Colloidal  silicon dioxide powder should be stored in well-closed
container.
Incompatibilities: Incompatible with diethylstilboestrol preparations.                     
Safety:  Colloidal  silicon  dioxide  is  widely  used  in  oral  and  topical  pharmaceutical
products and is generally regarded as an essentially non-toxic and non-irritant excipients
MAGNESIUM STEARATE46
Nonproprietary Names
BP : Magnesium stearate 
JP : Magnesium stearate
PhEur : Magnesii stearate
USPNF : Magnesium stearate
Synonyms
Magnesium  octadecanoate,  octadecanoic  acid,  magnesium  salt,  stearic  acid,
magnesium salt.
Chemical Name 
Octadecanoic acid magnesium salt 
CAS Register Number : [557-04-0]
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Empirical Formula 
C36H70MgO4
Structural Formula
CH3(CH2)16COO
Mg
CH3(CH2)16COO
Molecular Weight : 591.34 
Functional Category
Tablet lubricant.
Applications in Pharmaceutical Formulation or Technology
Magnesium stearate is widely used as a lubricant.
Description
It is a very fine, light white, precipitated powder of low bulk density, having a
faint odor of stearic acid with a characteristic taste and greasy to the touch and readily
adheres to the skin. Practically insoluble in ethanol, ether and water; slightly soluble in
warm benzene.
Typical properties
Density (bulk)   : 0.519 g/cm3
Density (tapped) : 0.289 g/cm3
Density (true) : 1.092 g/cm2
Flash point  : 250°C
      Flowability             : poorly flowing,cohesive powder
Melting range :117-150°C (commercial samples)
                                      126-130°C (high purity magnesium strearate)
Solubility        : practically insoluable in ethanol,ether and water,slightly 
  soluable in warm  benzene and warm water
Specific surface area    :1.6 – 14.8 m2/g
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Stability and Storage Conditions
Magnesium stearate is stable and should be stored in a well-closed container in a
cool, dry place.
Incompatibilities
Incompatible with strong acids, alkalis, iron salts and strong oxidizing materials.
Safety
Magnesium Streate has not been shown to be carcinogenic when implanted into
the bladder of mice.LD50  (rat,inhalation) : > 2mg/L
LD50 (rat,oral) : > 10 g/kg
SUCRALOSE46
Non proprietary Names: USPNF: Sucralose
Synonyms: 
Splenda;sucralosa;sucralosum;SucraPlus
Chemical Name
1,6-Dichloro-1,6-dideoxy-β-D-fructofuranosyl-4-chloro-4-deoxy-α  D-
galactopyranoside -E955, Trichlorosucrose 
CAS Registry Number :[56038-13-2]
 Structural formula: 
 Empirical Formula : C12H19Cl3O8 
 Molecular Weight : 397.63 
Functional Category :
Use as a sweetner in pharmaceutical formulation
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Applications in pharmaceutical formulation or Technology
Sucralose  is  used  as  a  sweeting  agent  in  beverages,foods,and  Pharmaceutical
applications.I has a sweetening power approximately 300-1000 times that of sucrose and
no aftertaste.In food products Sucralose used in concentration of 0.03- 0.2%.
Description
It is a white to off-white colour, free –flowing,crystalline powder.
Typical Properties
 Density (bulk)    : 0.35 g/cm2
 
 Density (tapped) : 0.62 g/cm2
 Melting point        : 130 ° C (for anhydrous crystalline form)
                               : 36.58°C (for pentahydrate)
Solubility               : freely soluable in ethanol,methanol and water,slightly soluable in 
  ethyl acetate.
Stability and Storage Conditions
          Sucralose is a relatively stable material. In aqueous solution, at highly acidic
conditions (pH < 3),and at high temperatures (35°C),it is hydrolyzed to limited extend
,producing 4-chloro-4 deoxygalactose and 1,6- dichloro-1,6 –dideoxyfructose.Sucralose
should be  stored in  a  well-  closed  container  in  a  cool,dry place,at  a  temperature not
exceeding 21°C.
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Preformulation Studies
Preformulation  is  the  first  step  in  the  formulation  studies.It  includes  the
application of biopharmaceutical  principles to the physiochemical properties of a drug
with the goal of designing an optimum drug delivery system which is stable,bioavaliable
and can be mass-produced2.
 Organoleptic Evaluation 
Organoleptic characters of drug was observed and recorded by  using descriptive 
terminology.Following physical properties of API were studied.
• Color
• Odor
• Taste
 Analytical Evaluation
• IR Spectroscopic Analysis
• UV Spectroscopical Analysis
• IR Spectroscopic  Analysis
Milnacipran  Hydrochloride,  placebo  and  final  lubricated  blend  of  orally
disintegrating tablets were analyzed by Infra Red spectroscopy (FTIR 8400S) by KBr
pellet method.They are compressed under high pressure in a hydraulic press to form a
transperant pellet.The pellet was scanned from  4000cm-1  to 400cm-1 in FTIR.The change
in  the  obtained  peaks  of  pure  drug,excipients  were  compared  with  drug-excipients
mixture. 
Determination of λmax  of selected candidate.
Preparation of medium ( 0.1N Hydrochloric acid)
8.5 ml of hydrochloric acid was diluted with distilled water and volume made upto
1000 ml
Procedure for the determination of λmax
A solution of Milnacipran  Hydrohloride a containing conc. 10µg/ml was prepared
in 0.1 N  Hydrochloric acid and UV spectrum was taken using Systronic 118 (UV-1800)
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spectrophotometer. The solution was scanned in the range of 200-400nm.
• UV spectroscopic Analysis
Preparation of Calibration Curve of Milnacipran Hydrochloride32,52
For preparation of the stock,  the drug Milnacipran Hydrochloride (100 mg) was
dissolved in 100 ml of 0.1N Hydrochloride to obtain a stock solution (1000 µg ).10 ml of
solution was taken and further diluted to 100 ml. The obtained solution of Milnacipran
Hydrochloride (100 µg/ml) was used as standard stock solution.
From the stock solution 5,10,15,20,25,and 30 µg/ml. Absorbance of each solution
was measured at 223 nm using  UV / Visible spectrophotometer.
The following studies were done for Milnacipran Hydrochloride and for all the
formulations.
a) Bulk Density (Db)53
It  is  the  ratio  of  total  mass  of  powder  to  the  bulk  volume  of  powder.It  was
measured by pouring the weighed powder (passed through standard sieve # 20) into a
measuring  cylinder and the intial volume was noted.This initial volume is called the bulk
volume.From this, the bulk density is calculated according to formula mentioned below.it
is expressed in g/ml and is given by
                     Db = M / Vo
                     M  - The mass of powder
                     Vo - The bulk volume of powder ( ml)
b) Tapped Density53
It is the ratio of total mass of powder to the tapped volume of powder.Volume was
measured by tapping the powder for 500, 750 times and the tapped volume was noted. if 
the difference between these two volumes is less than 2%  the volume was taken as 
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tapped volume.If it is more than 2% tapping is continued for 1250 times and tapped 
volume was noted.Tapping  was continued until the difference between successive 
volumes is less than 2%.It is expressed in g/ml and is given by
            Dt = M / Vf
Where,
      M –  The mass of powder
      Vf – The tapped volume of the powder.
C) Compressibility   Index53   (Carr’s   Index)
             Compressibility is the ability of powder to decrease in volume under pressure.
Compressibility  is a measure that is obtained from density determinations.It is one of the
simple method  to evaluate the flow property of powder by comparing the bulk  density
and tapped density.
                Carr’ s index= 100(Vo –Vf) / Vo
TableNo: 4 Relationship between % Compressibility and Flowability
D) Hausner’s  ratio53
 It is an indication of degree of densification.The hausner ratio of the
powder was determined by the following equation              
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% Compressibility Flow character
5 –12 Excellent
12 –16 Good
18 –21 Fair Passable
23 –35 Poor
33 –38 Very Poor
< 40 Very Very Poor
EXPERIMENTAL WORK
Hausner’s ratio = Vo/Vf
         Lower hausner ratio (<1.25) indicates better flow properties than higher ones
( >1.25).
Angle of Repose53 ( )
The frictional force in a loose powder or granules can be measured by angle of
repose. 
Angle of repose is the maximum angle between the surface of a pile of powder
and  horizontal  plane,It  is  usually  determined  by  fixed  funnel  method  suggested  by
Newmann and is the measure of flow ability of powder / granules.
A funnel with 10 mm inner diameter of stem was fixed at a height of 6 cm,over
the platform.About 25 gm of sample was slowly passed along the wall of the funnel till of
the pile formed and touches the stem of the funnel,A rough circle was drawn around the
pile base and the radius of the powder cone was measured.
tan  θ  =  h/r
       θ  =  tan-1 (h/r)
Where,
      θ     =  Angle of repose
      h     =  Height of the pile
      r      =  Average radius of the powder cone                   
TableNo. 5 Angle of repose as an indication of powder flow properties
Ultra College of Pharmacy, Madurai          PAGE 52
EXPERIMENTAL WORK
Formulation Development
In  this  work, direct
compression method  with  the
aid  of superdisintegrants
was  attempted  for the  formulation
development  of  rapid  dissolving  tablets  of  Milnacipran  Hydrochloride.  12.5  mg  of
Milnacipran Hydrochloride was selected for the present study with an average weight of
100mg tablet.  
Development of the formulation in the present study was mainly based on the type
and  concentration  of  superdisintegrant  and  the  properties  of  the  drug.  Various
superdisintegrant in different concentrations (3% and 5%) were used so as to get tablets
with good physical  properties.  The formulation design of  rapid dissolving tablets of
Milnacipran  Hydrochloride is shown in Table 
Table no.6 Formulation design of Milnacipran Hydrochloride Orally dissolving
tablets
mg/tab
Ingredients F1 F2 F3 F4 F5 F6 F7
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Angle   of repose Flow
¿ 25 Excellent
20-30 Good
30-40 Passable
¿ 40 Very poor
EXPERIMENTAL WORK
Milnacipran Hydrochloride 12.5 12.5 12.5 12.5 12.5 12.5 12.5
Mannitol (Pearlitol SD200) 70.5 70.5 70.5 70.5 72.5 72.5 70.5
Crosscarmellose sodium 5
Crospovidone 5 3 2.5
Sodium Starch Glycolate 5
KyronT-134(Polacrillin
Potassium
5 3 2.5
Aerosil200(Colloidal
Silicondioxide)
2 2 2 2 2 2 2
Povidone 4 4 4 4 4 4 4
Magnesium stearate 1 1 1 1 1 1 1
Sucralose 3 3 3 3 3 3 3
Vanilla flavor 2 2 2 2 2 2 2
Total Weight 100 100 100 100 100 100 100
Procedure for Direct Compression Method23
 Accurately weigh Milnacipran Hydrochloride, filler, superdisintegrants,sweetner
and flavour.
 Sift all the excipients through ASTM # 40.
 Mix all  the  excipient  with  drug  and  blend  the  sifted  material  together  for  5
minutes.
 Weigh and sift magnesium stearate through ASTM # 60.
  Lubricate the blend with sifted magnesium stearate for 2 minutes.
 Compress the above blend in CEMACH mini Rotary Tableting Machine using
8mm concave punches, upper punch embossed with “c” with the average weight
of 100 mg.
EVALUATION OF TABLETS
1. Post-compression parameter
The tablets   were evaluated for in-process and finished product quality
control  tests  i.e.,  weight  Variation,  Thickness,  Hardness,  Friability,  Tensile
strength,   Drug  content,  in  vitro dispersion  time,  Disintegration  time,  water
absorption ratio, wetting time and in vitro drug release studies
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 Weight Variation:55
The test  ensures that  all the tablets in each batch are of same potency,  within
reasonable  limits.  According  to  weight  variation  test,  20  tablets  were  weighed
individually and collectively. Average weight per tablet was calculated from the collective
weight. then the weights of the individual tablets were compared with the average weight
to determine the weight variation.
                                                          
 Tablet Crushing Strength57
Crushing  strength  (Hardness)  is  a  force  required  to  break  a  tablet  across  the
diameter. The hardness of a tablet is an indication of its strength. The tablet should be
stable to mechanical stress during handling and transportation. The degree of hardness
varies with the different manufactures and with the different types of tablet.
In  process  tablet  crushing  strength  were  measured  using  Monsanto  Hardness
Tester.
Post  compression  tablets  of  optimized  tablets  of  were  evaluated  for  crushing
strength using  TA XT plus,Stable Microsystems,UK.The Tablet tensile strength is the
force required to break a tablet by compressing it in radial direction.55
Preliminary Setting of Texture Analyser                                              
Table.No.7 TA settings and Parameters
Sequence Title Return to Start
Test Mode Compression
Pre-test Speed 2.0 mm/sec
Test speed 0.03 mm/sec
Post test speed 10.0 mm/sec
Target mode Distance
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Distance 0.5 mm
Trigger Type Auto (force)
Trigger Force 100g
Probe p/25 diameter
Points per second 500
The tablet crushing strength (TCS) was calculated using the formula (as per USP
monograph( <1217>).
Where
θx   is the tensile strength,
F  is the breaking force,
D  is the tablet diameter,
H  is the tablet thickness, and
W  is the central cylinder thickness
 Thickness53
            Thickness of tablets indicates the strength to withstand compression force applied
during manufacturing process. Thickness of tablets was measured by digital caliper.It is
expressed in millimetre.
 Friability53
Friability test was performed to assess the effect of friction and shock which may
often cause tablets to chip,cap or break.. Friability of tablets was determined using Roche
Friabilator . 20 tablets were taken in a friabilator and was operated for 100 revolutions in
25 RPM and tablets were weighed again. Tablets should not lose more than 1% of their
weight.
 Wetting Time And Water Absorption Ratio23
Wetting time of dosage form is related with the contact  angle. Wetting
time of the mouth dissolving tablets is another important parameter, which needs
Ultra College of Pharmacy, Madurai          PAGE 56
EXPERIMENTAL WORK
to be assessed to give an insight into the disintegration properties of the tablets; a
lower wetting time implies a quicker disintegration of the tablet.
                 It is obvious that pore size becomes smaller and wetting time increases
with an increase in compression force or a decrease in porosity.
Five  circular  tissue  paper  were  placed  in  a  petric  dish  with  a  10  cm
diameter.Ten millilitres of water containing eosin,a water soluable dye was added
to the petricdish.The dye solution is used to identify the complete wetting of the
tablet surface.A tablet was carefully placed on the surface of tissue paper in the
petricdish at  room temperature.The time required for water to reach the upper
surface and wet the tablets completely wet was noted as the wetting time. The
measurements were carried out in replicates.
The  same  procedure  was  repeated  for  determining  water  absorption
ratio.The wetted tablet was then weighed.Water absorption ratio,was determined
using the formula.
               
                           R     =  (Wa – Wb) / Wa × 100
Wa     =  Weight of the tablet after wetting
Wb     =  Weight of the tablet before wetting
 Drug Content53
20  were  weighed  and  tablets  were  weighed  and  titurated.in  motor.The  tablet
triturate equivqlent to 12.5mg of drug was d accurately weighed and diluted in 0.1N
Hydrochloric  acid  .The  diluted  solutions  absorbance  was  determined  by  UV
spectrophotometer at 223nm aganist the blank. The drug content should be within 90 %
to 110% of the labelled claim.
 Uniformity of dosage forms 53
Uniformity of dosage units is defined as the degree of uniformity in the amount of
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drug substance in each unit.
As per (USP 30 NF 25) uniformity of dose units was performed.
Table for Application of content uniformity (CU) and weight variation test (WV)
for tablet dosage form USP was presented below.
TABLETS
Dose andRatio
of drug
substance
>25mg & >25
%
Dose and Ratio
of drug
substance <
25mg & <25 %
Uncoated - WV CU
Coated Film coated WV CU
others CU CU
Uniformity of  Dosage  units  performed by content  uniformity method because
percentage of drug is less than 25 mg.
 Content Uniformity53
10 dosage units are weighed and dissolved in 0.1N Hydrochloric acid separately. 
Diluted solutions are assayed individually and acceptance value is calculated.
                 Acceptance Value = M -|X| + ks
M – Reference Value
X – Mean of individual contents
K – Acceptability Constant [if n =10 then k =2.4 and if n= 30 then k = 2 ]
s-   Sample Standard deviation.
 Disintegration Time53
The Invitro disintegration time was determined using disintegration test apparatus.
Six tablet were placed individually in each test tube of disintegration test apparatus . . The
Ultra College of Pharmacy, Madurai          PAGE 58
EXPERIMENTAL WORK
time taken for each tablet to disintegrate completely was recorded.
 In-vitro Dispersion Time
In  vitro  dispersion  time  was  measured  by  dropping  a  tablet  in  petricdish
containing 6 ml of water.Three tablets from each formulation were randomly selected and
invitro dispersion time was performed.
 In-vitro Dissolution Parameters48
As per  FDA Dissolution  Data  base  the  recommended dissolution medium for
Milnacipran Hydrochloride is  0.1N Hydrochloric acid.  Hence 0.1N Hydrochloric acid
was selected as a medium.
Following conditions were followed to study in-vitro dissolution of formulations.
Dissolution apparatus    : USP – I (Paddle)
Dissolution Medium            :  0.1 N Hydrochloric acid
Volume of dissolution fluid :  900 ml
Temperature                          :  37 ± 0.5°C
RPM                                     :  50
Samples were withdrawn at  2, 5, 10, 15, 20 and 30 minutes time intervals by
replacing with same dissolution medium.
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         RESULTS AND DISCUSSION
PREFORMULATION  STUDIES
Organoleptic Evaluation 
 Milnacipran Hydrochloride is white to off white crystalline powder,odourless, and  is
slightly bitter.Bitter taste were masked by using sweeting agent.
Analytical Evaluation
 I.R Spectroscopic Analysis
Fig.No.4  FTIR Spectrum of  Milnacipran Hydrochloride
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Table .no.8 IR Spectral Data for Milnacipran Hydrochloride
S.No Wave Number in Cm-1 Group Assigned
1. 2973.28 C-H-Streching
2. 1615.85 C=0 Streching
3. 1570.63 C=C Streching 
4. 1240.76 C-N Streching
5. 862.78 C-H Deformation 
Fig.no 5 FTIR Spectrum for Blend
Table.No.9  IR Spectral Data for Blend
S.No Wave Number in Cm-1 Group Assigned
1. 3401.03 O-H-Streching
2. 3292.02 N-H Streching
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3. 2950.03 C-H Streching 
4. 877.31 C-H Deformation
5. 1019.09 C-O Streching 
6. 1284.29 C-N Streching
7. 1725.17 C-O Streching
8. 1423.53 C=C Streching
9. 1082.81 C-O-C Streching
10. 780.31 C-CL Streching
Fig no.6 FTIR Spectrum of Placebo
Table.no.10.IR Spectral Data of Placebo
S.No Wave Number in Cm-1 Group Assigned
1. 3401.39 O-H-Streching
2. 2949.10 C-H Streching
3. 1617.64 C=O Streching 
4. 1426.64 C=C Streching
5. 1284.10 C-N Streching 
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6. 1082.81 C-O-C Streching
7. 1019.09 C-O Streching 
8. 698.36 C-Cl Streching
9. 875.97 C-H Deformation
 
DISCUSSION
      Results indicates that,there is no interaction between Milnacipran Hydrochloride and
excipients used in the formulation.
PREPARATION  OF  STANDARD  CURVE  OF  MILNACIPRAN
HYDROCHLORIDE
The Absorbance of  Milnacipran Hydrochloride with different  concentrations in
0.1 N Hydrochloric acid were tabulated below
Table.No.11 Standard Curve of Milnacipran Hydrochloride
Concentration (µg/ml) Absorbance
5 0.231
10 0.452
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15 0.692
20 0.905
25 1.154
30 1.371
Fig no.7 CONCENTRATION Vs ABSORBANCE
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BULK  CHARACTERISATION
Evaluation of Milnacipran Hydrochloride
The  powder  was  evaluated  for  Bulk  density,  Tapped  Density,  Compressibility
index  and Hausner’s ratio.              
    
Table.No.12  Evaluation of Pure Drug
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Sampl
e
Bulk
Density
(gm/ml)
Tapped
Density
(gm/ml)
Percentage
Compressibility
(Carr’s index)
Hausner’s
ratio
Angle of
Repose
()
Pure
Drug
0.491 ± 002 0.621 ± 0.03 18.28 ± 0.04 1.166 ± 0.03 31012’± 0.31
Discussion
     The  above  result  indicate  that  the  Milnacipran  Hydrochloride  is  having  good
compressibility due to its crystalline structure.Angle of repose of drug was found to be in
the range of  Passable (as  per  USP),  which  may due to  its  irregular  partical  size and
particle size distribution.
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FORMULATION DEVELOPMENT
Formulation development of Milnacipran Hydrochloride was performed by direct
compression
The Physical Characteristics of the prepared blend was performed and the results
were given below
             
Table.NO.13   Evaluation of Directly Compressible Blend
Sl.n
o
Parameters F1 F2 F3 F4 F5 F6 F7
1 Bulk  Density
(g/ml)
0.412
± 0.02
0.401
± 0.03
0.406
± 0.04
0.423
± 0.02
0.414 ±
0.02
0.409 ±
0.03
0.427
± 0.02
2 Tapped Density
(g/ml)
0.471
± 0.03
0.455
± 0.02
0.453
± 0.03
0.482
± 0.02
0.471 ±
0.03
0.458 ±
0.02
0.489
± 0.02
3 Compressibilit
y index ( % )
12.4 11.88 10.37  12.2 12.10 10.69 12.67
4 Hausner’s
Ratio
1.14 1.13 1.11 1.13 1.13 1.11 1.14
5 Angle of 
repose
300 33’ 260 29, 290 67’ 270 45, 280 34, 29 023, 28089,
Discussion
From  the  obtained  results  it  was  found  that  all  the  batches  have  good  flow
property and compressability. as per USP specifications.
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SELECTION OF DISINTEGRANT   
To select  a  disintegrants  batch  with  Crospovidone,Kyron,T-314,Croscarmellose
sodium.,Sodium  starch  Glycolate  with  maximum  concentration  were  taken  and  it  is
checked for the physio chemical properties of the tablet. Among the batches taken the
tablets with Sodium Starch Glycolate as a disintegrants shows maximum dispersion time.
Sodiumstarch Glycolate is having 2 minute 15 seconds  and Croscarmellose sodium is
having 1 minute 36 seconds  were as, kyron T-314 and Crospovidone shown dispersion
time of 24 seconds and 26 seconds respectively.Hence Crospovidone and Kyron T-314
were selected for further trials .
Batches with 3 % of Crospovidone and 3 % Kyron T-314  was taken and it
shown that dispersion time was more than 30 seconds. Hence to reduce the dispersion
time  batch  with  Kyron  T-314  and  Crospovidone  of  2.5  %  each  were  taken  .It  was
observed that it is showing dispersion time of 21 second.To optimise the final formula
dissolution  studies  were  performed  on  batchs  with  5%Kyron  T-314,  5%
Crospovidone,and batchs with disintegration combination (2.5% each) of Kyron T-314
and Crospovidone.
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Table.No.14   Evaluation of optimized formulations of F2, F4 and F7
Evaluation Parameters F2 F4 F7
Weight  Variation (mg) 99.56 ± 0.3 100.08 ± 0.5 99.65 ± 0.6
Thickness (mm) 2.13 ± 0.3 2.11 ± 0.3 2.10 ± 0.2
Inprocess Crushing Strength by 
Monsanto Hardness Tester(kg/cm2)
1.75 ± 0.3 1.80 ± 0.4 1.85 ± 0.4
Friability (%) 0.36 ± 0.05 0.38 ± 0.07 0.35 ± 0.02
Disintegration Time  (sec) 20 18 16
Dispersion Time (sec ) 26 24 21
Wetting Time (sec) 23 ± 1.22 24 ± 1.53 19 ± 1.26
Water Absorption Ratio (% ) 65 ± 0.53 67 ± 0.25 62 ± 0.87
Drug Content 99.6 ± 1.57 99.9 ± 1.65 100.1 ± 1.48
Content Uniformity (L1 Value ) 1.72 1.69 1.54
 Tablet Crushing Strength
by TA XT Plus Analyser(N/mm2)
1.08 ± 0.6 1.02 ± 0.6 1.12 ± 0.06
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Fig.no.8  Texture Analysis by TA XT Plus Analyser
Discussion
The  percentage  weight  variations  for  all  batches  were  found  to  be  within  the
Pharmacopeial limit. All the batches showed weight uniformity
The  crushing  strength  of  all  batches  was  almost  uniform  and  possess  good
mechanical strength with sufficient hardness.
The  percentage  friability  of  all  batches  was  below  1%  indicating  that  all
formulation possess good mechanical strength.
The disintegration time of all the batches were found to be almost less than 30 sec
The drug content and the uniformity of dosage forms of all the three batches was
found within the limits as per US pharmacopeia
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INVITRO DISSOLUTION STUDIES OF OPTIMIZED FORMULATIONS
Table.No.15 IN VITRO DISSOLUTION STUDY OF BATCH F2
Time (min ) Cumulative % drug Release
2 46.18
5 70.8
10 75.3
15 80.4
20 85.6
25 90.2
30 95.6
Fig.no.9 Time Vs Cumulative % drug release
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Table.No.16  INVITRO DISSOLUTION STUDY OF BATCH F4
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Time  (min) Cumulative % drug Release
2 48.62
5 70.3
10 78.6
15 83.9
20 88.5
25 92.5
30 97.3
Fig.no.10 Time Vs Cumulative % of drug
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Table .No.17 INVITRO DISSOLUTION  STUDY OF BATCH F7
Time  (min) Cumulative % drug Release
2 70.2
5 86.7
10 94.4
15 95.3
20 97.4
25 98.6
30 99.8
Ultra College of Pharmacy, Madurai           PAGE 71
RESULTS AND DISCUSSION
Fig.no.11  Time Vs Cumulative % of drug
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Fig.no.12 Comparative dissolution Profile of F2,F4 and F7 batches
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Discussion
Comparative  dissolution  data  shows  that  batch  with  Kyron  T-314  and
crospovidone (2.5% each) is giving better dissolution rate compared to other two batches.
Hence the formula was considered as the finalized formula. 
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SUMMARY
Oro dispersible tablets of Milnacipran Hydrochloride is an anti depressant drug
which is highly appropriate as it has ease of administration for the patients having major
depressive disorder.
Orodispersible tablets (ODT) have better patient acceptance and compliance ,may
offer  improved patient compliance compared with conventional oral dosage forms as the
drug dissolves in saliva within a matter of seconds.
Literature regarding drug,  excipients  selection,  manufacturing method,  etc,  has
been  collected  and  reviewed.  Analytical  method  was  developed  for  Milnacipran
Hydrochloride using UV-spectrophotometer at 223nm.It obeys beer-lamberts law between
4-40 g/ml. 
FTIR study of the pure drug and Final Lubricated blend was performed and result
confirms that the drug is compatabile with other excipents.
Pre-compression parameters such as bulk density tapped density, compressibility
index, hausner’s ratio and angle of repose were performed and results indicate that all the
final lubricated blends   are having good flow property.
Initial trials with Sodium Starch Glycolate ,Crospovidone, Crosscarmelose sodium
and  Kyron  T-314  were  taken  with  5%of  superdisintegrant.  Among  these  batches
taken,kyron  T-314  and  crospovidone  shows  better  dispersion  time  within  30  seconds
compared to the other two superdisintegrants.
To  optimize  the  concentration  of  superdisintegrant  batches  with  5%  of
crospovidone, 5% kyron T-314 and batch with 2.5% of crospovidone and 2.5 % of kyron
T-314 were taken .Dispersion Time of batches mentioned are  sec,26 sec and 20 seconds
respectively.
Post  compression  parameters  such  as  weight  variation,  hardness,  thickness,
friability and drug content,uniformity of  dosage forms were performed and tablets  of
these  formulation   were  found  to  be  within  the  limits.   To  select  a  final
formula,dissolution profiling of all the three batches were performed and found that batch
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with kyron T-134 and crospovidone (2.5% each) given better rate of dissolution than other
two batches.Hence the batches with both disintegrant was selected as a final formula.
Here, the vital rationale of developing the oral disintegrating tablet was achieved.
Formulation F7 showed the disintegration within 20 sec and the dispersion time at 21 sec
by using the combination of  crospovidone and Kyron  T-314 as a superdisintegrants. as
the concentration increases.dispersion time also get decreases..
CONCLUSION
The formulation of oro dispersible tablets of Milnacipran hydrochloride complines
all the requirements of mouth dissolving tablet .
From   the  results  of  the  study  we  conclude  that  formula  F7  (mannitol
crospovidone,Kyron  T-314,povidone  ,magnesium stearate  ,sucralose,Vanilla)  processes
good disintegration  and  dissolution  profile  with  the  addition  of  superdisintegrants.On
comparing  all the batches, F7 passess all the quality control tests 
Milnacipran  Hydrochloride  is  not  avaliabe  as  a  patient  compliance  orally
disintegrating  tablet  dosage  form  in  market.Hence  by preparing  Orally  disintegrating
tablet  of Milnacipran hydrochloride ,the fulfilment and speedy recovery of patients is
possible in future.
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